S100A8/A9 in Inflammation

被引:1251
作者
Wang, Siwen [1 ,2 ]
Song, Rui [1 ,2 ]
Wang, Ziyi [1 ,2 ]
Jing, Zhaocheng [1 ,2 ]
Wang, Shaoxiong [1 ,2 ]
Ma, Jian [1 ,2 ,3 ]
机构
[1] Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China
[2] Cent S Univ, Canc Res Inst, Xiangya Sch Med, Changsha, Hunan, Peoples R China
[3] Minist Educ, Hunan Key Lab Nonresolving Inflammat & Canc, Key Lab Carcinogenesis & Canc Invas, Key Lab Carcinogenesis,Minist Hlth, Changsha, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
S100A8; S100A9; inflammation; infection; biomarker; MYELOID-RELATED PROTEINS; CALCIUM-BINDING PROTEINS; PERITONEAL-EXUDATE CELLS; DISTINCT MOLECULAR SIGNATURES; APOPTOSIS-INDUCING ACTIVITY; HUMAN GINGIVAL FIBROBLASTS; ACUTE CORONARY SYNDROMES; INCREASED SERUM-LEVELS; END-PRODUCTS RAGE; ALZHEIMERS-DISEASE;
D O I
10.3389/fimmu.2018.01298
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
S100A8 and S100A9 (also known as MRP8 and MRP14, respectively) are Ca2+ binding proteins belonging to the S100 family. They often exist in the form of heterodimer, while homodimer exists very little because of the stability. S100A8/A9 is constitutively expressed in neutrophils and monocytes as a Ca2+ sensor, participating in cytoskeleton rearrangement and arachidonic acid metabolism. During inflammation, S100A8/A9 is released actively and exerts a critical role in modulating the inflammatory response by stimulating leukocyte recruitment and inducing cytokine secretion. S100A8/A9 serves as a candidate biomarker for diagnosis and follow-up as well as a predictive indicator of therapeutic responses to inflammation-associated diseases. As blockade of S100A8/A9 activity using small-molecule inhibitors or antibodies improves pathological conditions in murine models, the heterodimer has potential as a therapeutic target. In this review, we provide a comprehensive and detailed overview of the distribution and biological functions of S100A8/A9 and highlight its application as a diagnostic and therapeutic target in inflammation-associated diseases.
引用
收藏
页数:14
相关论文
共 166 条
[1]
Myeloid-Related Protein-14/MRP-14/S100A9/Calgranulin B is Associated with Inflammation in Proliferative Diabetic Retinopathy [J].
Abu El-Asrar, Ahmed M. ;
Alam, Kaiser ;
Siddiquei, Mohammad M. ;
Van den Eynde, Kathleen ;
Mohammad, Ghulam ;
De Hertogh, Gert ;
Opdenakker, Ghislain .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (04) :615-624
[2]
Myeloid-related protein-14 deficiency promotes inflammation in staphylococcal pneumonia [J].
Achouiti, Ahmed ;
Vogl, Thomas ;
Van der Meer, Anne J. ;
Stroo, Ingrid ;
Florquin, Sandrine ;
de Boer, Onno J. ;
Roth, Johannes ;
Zeerleder, Sacha ;
van 't Veer, Cornelis ;
de Vos, Alex F. ;
van der Poll, Tom .
EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (02) :464-473
[3]
Myeloid-Related Protein-14 Contributes to Protective Immunity in Gram-Negative Pneumonia Derived Sepsis [J].
Achouiti, Ahmed ;
Vogl, Thomas ;
Urban, Constantin F. ;
Rohm, Marc ;
Hommes, Tijmen J. ;
van Zoelen, Marieke A. D. ;
Florquin, Sandrine ;
Roth, Johannes ;
van't Veer, Cornelis ;
de Vos, Alex F. ;
van der Poll, Tom .
PLOS PATHOGENS, 2012, 8 (10)
[4]
FASTTRACK -: Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion:: a novel, early, and sensitive marker of acute coronary syndromes [J].
Altwegg, Lukas A. ;
Neidhart, Michel ;
Hersberger, Martin ;
Mueller, Simone ;
Eberli, Franz R. ;
Corti, Roberto ;
Roffi, Marco ;
Suetsch, Gabor ;
Gay, Steffen ;
von Eckardstein, Arnold ;
Wischnewsky, Manfred B. ;
Luescher, Thomas F. ;
Maier, Willibald .
EUROPEAN HEART JOURNAL, 2007, 28 (08) :941-948
[5]
S100-alarmins: potential therapeutic targets for arthritis [J].
Austermann, Judith ;
Zenker, Stefanie ;
Roth, Johannes .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (07) :739-751
[6]
Alarmins MRP8 and MRP14 Induce Stress Tolerance in Phagocytes under Sterile Inflammatory Conditions [J].
Austermann, Judith ;
Friesenhagen, Judith ;
Fassl, Selina Kathleen ;
Ortkras, Theresa ;
Burgmann, Johanna ;
Barczyk-Kahlert, Katarzyna ;
Faist, Eugen ;
Zedler, Siegfried ;
Pirr, Sabine ;
Rohde, Christian ;
Mueller-Tidow, Carsten ;
von Koeckritz-Blickwede, Maren ;
von Kaisenberg, Constantin S. ;
Flohe, Stefanie B. ;
Ulas, Thomas ;
Schultze, Joachim L. ;
Roth, Johannes ;
Vogl, Thomas ;
Viemann, Dorothee .
CELL REPORTS, 2014, 9 (06) :2112-2123
[7]
Bassorgun CI, 2014, GASTROENT RES PRACT, V2014, DOI [10.1155/2014/, DOI 10.1155/2014/]
[8]
HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-κB activities [J].
Benedyk, Malgorzata ;
Sopalla, Claudia ;
Nacken, Wolfgang ;
Bode, Guenther ;
Melkonyan, Harut ;
Banfi, Botond ;
Kerkhoff, Claus .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (08) :2001-2011
[9]
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus [J].
Bengtsson, Anders A. ;
Sturfelt, Gunnar ;
Lood, Christian ;
Ronnblom, Lars ;
van Vollenhoven, Ronald F. ;
Axelsson, Bengt ;
Sparre, Birgitta ;
Tuvesson, Helen ;
Ohman, Marie Wallen ;
Leanderson, Tomas .
ARTHRITIS AND RHEUMATISM, 2012, 64 (05) :1579-1588
[10]
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides [J].
Bjork, Per ;
Bjork, Anders ;
Vogl, Thomas ;
Stenstrom, Martin ;
Liberg, David ;
Olsson, Anders ;
Roth, Johannes ;
Ivars, Fredrik ;
Leanderson, Tomas .
PLOS BIOLOGY, 2009, 7 (04) :800-812